Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation

G. Camussi, F. Bussolino, F. Ghezzo, L. Pegoraro

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Platelet-activating factor (PAF), a phospholipid mediator of anaphylaxis, is also known to be released in vitro from both phagocytic polymorphonuclear neutrophils (PMN) and monocytes in response to a variety of stimuli. The fact that human myeloid cells of the HL-60 line can be made to differentiate in vitro into macrophage-like cells by 12-O-tetradodecanoylphorbol-13-acetate (TPA) prompted us to investigate the generation and release of PAF during this transformation. Both passive release of PAF at pH 9.5, and active release, following phagocytosis of C3b- and C3d-opsonized yeast spores, and stimulation with C5a anaphylatoxin from untreated and TPA-treated HL-60 cells, PMN, and plastic-adherent normal human monocytes were studied. It was found that after 3 days of TPA treatment, HL-60 cells released PAF following phagocytosis of C3b- and C3d-opsonized yeast spores. Inhibition of PAF release by a selective inhibitor of phospholipase A2 and labeling of PAF with sodium 14C-acetate indicated that PAF generation is a two-step process: (1) release of PAF precursor from cell membranes and (2) its acetylation. A model for the in vitro study of mechanisms and metabolic events involved in PAF generation and release could perhaps be built on these findings.

Original languageEnglish
Pages (from-to)16-22
Number of pages7
JournalBlood
Volume59
Issue number1
Publication statusPublished - 1982

Fingerprint

Macrophages
Platelet Activating Factor
Acetates
HL-60 Cells
Spores
Phagocytosis
Yeast
Monocytes
Neutrophils
Yeasts
Anaphylatoxins
Sodium Acetate
Acetylation
Anaphylaxis
Myeloid Cells
Cell membranes
Labeling
Plastics
Phospholipids
Sodium

ASJC Scopus subject areas

  • Hematology

Cite this

Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation. / Camussi, G.; Bussolino, F.; Ghezzo, F.; Pegoraro, L.

In: Blood, Vol. 59, No. 1, 1982, p. 16-22.

Research output: Contribution to journalArticle

@article{ae892cc337d9402a8a0a3afd7ab67e20,
title = "Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation",
abstract = "Platelet-activating factor (PAF), a phospholipid mediator of anaphylaxis, is also known to be released in vitro from both phagocytic polymorphonuclear neutrophils (PMN) and monocytes in response to a variety of stimuli. The fact that human myeloid cells of the HL-60 line can be made to differentiate in vitro into macrophage-like cells by 12-O-tetradodecanoylphorbol-13-acetate (TPA) prompted us to investigate the generation and release of PAF during this transformation. Both passive release of PAF at pH 9.5, and active release, following phagocytosis of C3b- and C3d-opsonized yeast spores, and stimulation with C5a anaphylatoxin from untreated and TPA-treated HL-60 cells, PMN, and plastic-adherent normal human monocytes were studied. It was found that after 3 days of TPA treatment, HL-60 cells released PAF following phagocytosis of C3b- and C3d-opsonized yeast spores. Inhibition of PAF release by a selective inhibitor of phospholipase A2 and labeling of PAF with sodium 14C-acetate indicated that PAF generation is a two-step process: (1) release of PAF precursor from cell membranes and (2) its acetylation. A model for the in vitro study of mechanisms and metabolic events involved in PAF generation and release could perhaps be built on these findings.",
author = "G. Camussi and F. Bussolino and F. Ghezzo and L. Pegoraro",
year = "1982",
language = "English",
volume = "59",
pages = "16--22",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation

AU - Camussi, G.

AU - Bussolino, F.

AU - Ghezzo, F.

AU - Pegoraro, L.

PY - 1982

Y1 - 1982

N2 - Platelet-activating factor (PAF), a phospholipid mediator of anaphylaxis, is also known to be released in vitro from both phagocytic polymorphonuclear neutrophils (PMN) and monocytes in response to a variety of stimuli. The fact that human myeloid cells of the HL-60 line can be made to differentiate in vitro into macrophage-like cells by 12-O-tetradodecanoylphorbol-13-acetate (TPA) prompted us to investigate the generation and release of PAF during this transformation. Both passive release of PAF at pH 9.5, and active release, following phagocytosis of C3b- and C3d-opsonized yeast spores, and stimulation with C5a anaphylatoxin from untreated and TPA-treated HL-60 cells, PMN, and plastic-adherent normal human monocytes were studied. It was found that after 3 days of TPA treatment, HL-60 cells released PAF following phagocytosis of C3b- and C3d-opsonized yeast spores. Inhibition of PAF release by a selective inhibitor of phospholipase A2 and labeling of PAF with sodium 14C-acetate indicated that PAF generation is a two-step process: (1) release of PAF precursor from cell membranes and (2) its acetylation. A model for the in vitro study of mechanisms and metabolic events involved in PAF generation and release could perhaps be built on these findings.

AB - Platelet-activating factor (PAF), a phospholipid mediator of anaphylaxis, is also known to be released in vitro from both phagocytic polymorphonuclear neutrophils (PMN) and monocytes in response to a variety of stimuli. The fact that human myeloid cells of the HL-60 line can be made to differentiate in vitro into macrophage-like cells by 12-O-tetradodecanoylphorbol-13-acetate (TPA) prompted us to investigate the generation and release of PAF during this transformation. Both passive release of PAF at pH 9.5, and active release, following phagocytosis of C3b- and C3d-opsonized yeast spores, and stimulation with C5a anaphylatoxin from untreated and TPA-treated HL-60 cells, PMN, and plastic-adherent normal human monocytes were studied. It was found that after 3 days of TPA treatment, HL-60 cells released PAF following phagocytosis of C3b- and C3d-opsonized yeast spores. Inhibition of PAF release by a selective inhibitor of phospholipase A2 and labeling of PAF with sodium 14C-acetate indicated that PAF generation is a two-step process: (1) release of PAF precursor from cell membranes and (2) its acetylation. A model for the in vitro study of mechanisms and metabolic events involved in PAF generation and release could perhaps be built on these findings.

UR - http://www.scopus.com/inward/record.url?scp=0020034277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020034277&partnerID=8YFLogxK

M3 - Article

C2 - 6947829

AN - SCOPUS:0020034277

VL - 59

SP - 16

EP - 22

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -